Introduction
Oesophageal cancer is the ninth most common cancer and the sixth most common cause of cancer death worldwide 1 . The mainstay curative option for most patients with locally advanced cancer is oesophagectomy, often preceded by neoadjuvant therapy 2 . Surgical resection is associated with a high rate of postoperative morbidity, and health-related quality of life (HRQoL) can deteriorate substantially following surgery 3 . In recent years, minimally invasive techniques using a combination of thoracoscopic and/or laparoscopic approaches have been introduced with the aim of reducing surgical trauma, minimizing complications and enhancing postoperative recovery 4 . In addition to a few cohort studies, one RCT 5 has indicated that specific components of short-term HRQoL may be improved by employing a minimally invasive approach. However, there is great variability in the HRQoL outcomes assessed and the time after surgery at which these were evaluated 6, 7 . At present there is no evidence as to whether HRQoL in general is better following minimally invasive oesophagectomy compared with open surgery. In addition, if any specific HRQoL outcome differs between these approaches, the time frame for which these differences may persist after surgery is not known.
The aim of this meta-analysis was to assess differences in postoperative HRQoL outcomes over time after minimally invasive in comparison with open oesophagectomy for oesophageal cancer.
Search strategy
A comprehensive literature search was conducted in September 2016 using a keyword search on PubMed (MEDLINE), Web of Science, Embase, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Library, from the inception of each database. The following search string was used: (mini-invasiv* OR minimally-invasive OR minimally invasive OR vats OR thoraco* OR laparo*) AND (esophag* OR oesophag* OR gastro-oesophag* OR gastroesophag*) AND (neoplas* OR tumo* OR cancer OR carcinoma OR adenocarcinoma) AND (Quality of life OR qol OR hqol OR hrqol).
Study selection
Studies considered for inclusion in the systematic review and meta-analysis had the following characteristics: original studies, written in English and oesophageal cancer or high-grade dysplasia (HGD) as indications for oesophagectomy. Other inclusion criteria were HRQoL data assessed using any well validated HRQoL instrument or its derivative, HRQoL outcomes measured both before and after oesophagectomy, and postoperative HRQoL compared between minimally invasive and open surgical procedures.
Titles and abstracts of the identified studies were screened by one researcher. When a study met the eligibility criteria, or when information was insufficient to exclude the study, the full article was reviewed. Reference lists of the retrieved articles, PubMed 'related articles' and articles dealing with the literature review were scanned for potential additional studies. Full-text articles were studied independently by two authors. In the case of discrepancies, the studies were discussed between the authors based on the predetermined eligibility criteria until consensus was reached.
Data extraction
All data from eligible studies were extracted independently by two investigators to maintain the integrity of the data. Gathered information included the name of first author, publication year, study period, design, population characteristics (age and sex), treatment, number of patients in the two surgery groups, HRQoL indicators used, and HRQoL outcomes at baseline and different time points after surgery. First and corresponding authors in the eligible studies were contacted by e-mail up to three times to obtain unreported data.
Quality assessment
Study quality and bias were assessed separately by two authors using the Newcastle-Ottawa scale, as all but one of the included studies were cohort studies 9 . The predetermined items for assessment of study quality and results were used to rank the studies. Discrepancies between assessors were settled by discussion. Bias in individual studies was analysed qualitatively.
Definition of exposure and outcome
The study exposure was divided in two categories: minimally invasive and open oesophagectomy. Minimally invasive oesophagectomy included hybrid approaches, such as laparoscopically assisted, laparoscopic hand-assisted and thoracoscopically assisted, and wholly minimally invasive procedures. Open procedures included Ivor Lewis and left transthoracic thoracoabdominal oesophagectomy (with intrathoracic anastomosis), three-incision oesophagectomy (with neck anastomosis) and transhiatal oesophagectomy (with neck anastomosis).
The outcome of interest was HRQoL, a multidimensional measure consisting of physical health, psychological health, functional status, social relationships and personal beliefs 10 . HRQoL can be classified as generic or disease-specific, and is measured using a variety of scales and indicators. The HRQoL questionnaires used in the included studies were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 version 3.0 core questionnaire (EORTC QLQ-C30) measuring cancer-related functions and symptoms 11 , the EORTC oesophageal cancer-specific HRQoL module (EORTC QLQ-OES18) assessing disease-related symptoms and items 12 , the Short Form 36 (SF-36 ® ; QualityMetric, Lincoln, Rhode Island, USA) measuring general health 13 , the Multidimensional Fatigue Inventory (MFI-20) measuring different aspects of fatigue 14 , a modified Katz scale, and a modified Lawton and Brody scale measuring daily activities 15 . The HRQoL questionnaires used in the studies were checked for validity in the native languages of the country of origin of the study.
Statistical analysis
Statistical analyses were performed using Review Manager version 5.3 (The Cochrane Collaboration, Oxford, UK) and STATA ® version 13.0 (StataCorp, College Station, Texas, USA), according to the Cochrane guidelines for systematic reviews 9 . The number of patients in each treatment group was collected as reported in the individual studies. Standard deviations were calculated based on the standard error of the mean value and patient number at each time point for each of the two surgery groups. Missing data on standard deviations were imputed using the largest reported standard deviation for the outcome with the given surgical operation at a given time point 9, 16 . This approach was used to obtain the most conservative effect estimate. Data available only in graphical form were extracted using the WebPlotDigitizer tool (http://arohatgi.info/WebPlotDigitizer). In one included study 17 , two open oesophagectomy procedures were combined as suggested in the Cochrane handbook 9 . To evaluate potential bias due to imputation of standard deviations for two of the included studies, a sensitivity analysis was performed including only the studies that did not require any data to be imputed.
Continuous variables were analysed using inverse variance according to the DerSimonian-Laird method 18 . To obtain estimates of average treatment effects, a random-effects model was used to estimate mean differences (MDs) for continuous data across the studies 19 . MDs and pooled effects with 95 per cent confidence intervals are depicted as forest plots. Based on previous literature, MDs were considered clinically significant only when the pooled differences were at least 10 points, which correspond to at least a 'moderate' change or difference for the patients 20, 21 . Statistical heterogeneity of the studies was assessed in terms of the I 2 statistic 22 . An I 2 value lower than 25 per cent indicated minor inconsistency, and a value above 50 per cent indicated major inconsistency. As the random-effects meta-analysis calculates the average effect of a given treatment, 95 per cent prediction intervals were calculated for each outcome at a given time point to estimate the range of true difference between the treatments in 95 per cent of the population 19, 23 .
As the number of included studies was small, meta-regression could not be performed reliably 24 . Thus, a sensitivity analysis was undertaken by removing one study at a time in the meta-analysis to estimate the influence of each study on the pooled estimate of HRQoL scores. Potential publication bias and small-study effects of the clinically relevant HRQoL outcomes were analysed by visually inspecting the funnel plots instead of statistical testing, given the small number of included studies 25 .
Results
The search identified 2853 titles (Fig. 1) . A total of nine studies were eligible for qualitative analysis; they included 2064 patients, of whom 1157 (56⋅1 per cent) underwent minimally invasive surgery and 907 (43⋅9 per cent) underwent open surgery 5 -7,15,17,26-29 ( Table 1 ). The median number of patients per study was 114 (range 56-888). Three studies 17, 28, 29 included only patients with oesophageal squamous cell carcinoma, and one study 26 included only patients with adenocarcinoma. Five studies 5 -7,15,27 also included patients with cancer of the gastro-oesophageal junction, and two 7,15 included patients with high-grade dysplasia. The presence of medical co-morbidity was not described in two of the studies 15, 27 , whereas fitness evaluations with ASA grades were available for four studies 5, 6, 26, 29 . In the seven studies 5, 6, 15, 17, 26, 27, 29 that described the use of neoadjuvant therapy, 595 (32⋅4 per cent) of the 1836 patients received such treatment. The number of patients receiving postoperative chemotherapy or chemoradiotherapy was described in only one 26 of the nine studies.
Details of patients and surgery are described further in Tables 2 and 3 . The main open surgical procedure was the right-sided transthoracic (Ivor Lewis) oesophagectomy. No patient undergoing a transhiatal resection was included in the studies. There was variability in the anastomotic technique and location. Of patients who had minimally invasive surgery, at least 245 underwent totally minimally invasive oesophagectomy in five studies 5, 7, 15, 17, 26 . Five studies 6,15,27 -29 employed a hybrid approach or included both totally minimally invasive and hybrid minimally invasive oesophagectomy in the treatment group (912 patients). In summary, all studies included a minimally invasive group of patients who underwent thoracoscopy and an open oesophagectomy group of patients who had a thoracotomy.
The HRQoL outcomes were measured using both the EORTC QLQ-C30 and the QLQ-OES18 questionnaires in eight studies 5 -7,17,26-29 . In one study 15 , MFI-20 and activities of daily living questionnaires suggested decreased fatigue and an increased proportion of independent patients after minimally invasive surgery compared with open surgery at 3 and 6 months. One of the studies reported 1-week outcomes, three reported 2-week outcomes, four reported 4-week outcomes, and two studies reported 6-week outcomes. Eight of the studies measured HRQoL outcomes at 3 months, and seven at 6 months after surgery. Four studies measured 12-month HRQoL outcomes, and two also reported outcomes at 24 months. Reporting on HRQoL outcomes was generally selective; only three articles reported all or almost all of the numerical values for the EORTC QLQ-C30 and QLQ-OES18 questionnaire outcomes. Two studies 17, 28 did not present any numerical values, but instead provided graphs. Only one study 6 used evidence-based cut-off values for interpreting differences in the HRQoL scores 20, 21 . 
General cancer-related symptoms (EORTC QLQ-C30)
One study 15 that measured fatigue with the MFI-20 scale was excluded from the quantitative analysis; the study did not report general fatigue, and the subscales were not compatible with the fatigue scale in the EORTC questionnaire. The meta-analysis was conducted on 4-6-week and 3-, 6-and 12-month extracted outcome data on global quality of life, physical function, fatigue and pain from the eight included studies. Owing to the small number of studies reporting outcomes at time points of less than 6 weeks after surgery, outcomes at 4-6 weeks from five studies were combined and analysed. Clinical heterogeneity was found between the study populations, as there were differences between the sublocation and histology of the cancers, as well as the study design. The I 2 statistic indicated high statistical heterogeneity (above 50 per cent) for all of the analyses, except global quality of life at 4-6 weeks (I 2 = 25 per cent) and 12 months (I 2 = 9 per cent), fatigue at 12 months (I 2 = 0 per cent) and pain at 4-6 weeks (I 2 = 25 per cent). However, the baseline values for the studied outcomes in each study were similar in the treatment groups, with no MD greater than 5 points between surgery groups.
Meta-analysis of these key HRQoL outcomes showed that minimally invasive surgery was followed by better outcomes at 4-6 weeks (Fig. S1, supporting information) . The 3-month outcomes were also better after minimally invasive oesophagectomy for global quality of life (MD 11⋅61, 95 per cent c.i. 3⋅84 to 19⋅39), physical function (MD 11⋅88, 3⋅92 to 19⋅84), fatigue (MD −13⋅18, −17⋅59 to −8⋅76) and pain (MD −15⋅85, −20⋅45 to −11⋅24) (Fig. 2) . At 6 months there were no clinically significant MDs in HRQoL outcomes, except for physical function, which favoured minimally invasive surgery (MD 11⋅79, −0⋅40 to 23⋅97), but this difference was not statistically significant (Fig. S2, supporting information) . HRQoL at 12 months after surgery is shown in Fig. S3 (supporting information) . Fig. 3 shows the pooled differences of these key outcomes at different time points. The majority of the patients experienced better global HRQoL and less pain at 4-6 weeks, and less fatigue and pain at 3 months after surgery, as reflected by the 95 per cent prediction intervals (Fig. S4,  supporting information) . *Data for eight patients were not provided as they did not undergo resection owing to metastasis or unresectability; †one patient with benign tissue omitted. ‡Two groups: hybrid minimally invasive surgery and totally minimally invasive surgery. §Two groups: Ivor Lewis and left transthoracic oesophagectomy. ¶Data from Biere et al. 4 . #Duration of ICU stay. HGD, high-grade dysplasia; MIO, minimally invasive oesophagectomy; n.d., not described.
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Sensitivity analysis
In sensitivity analysis of the pooled results (excluding studies that used some imputed data), the observed pooled, clinically significant, differences at 3 months remained.
When one study at a time was omitted in the sensitivity analysis, one study 29 was found to make the 3-month difference of surgical method on global quality of life and physical function less relevant clinically, but the difference remained statistically significant (at 3 months: MD for global HRQoL 8⋅51, 95 per cent c.i. 5⋅58 to 11⋅43; MD for physical function 9⋅00, 4⋅66 to 13⋅35). Sensitivity analysis was also conducted excluding the studies involving hybrid minimally invasive operations. Based on pooled results from two to four studies at each time point, totally minimally invasive surgery had clinically (MD greater than 10 points) and statistically significant superior outcomes compared with open surgery until 3 months, but not at 6 months, similar to the main analysis. At 12 months, the difference in global HRQoL was not clinically significant.
Other key outcomes at 12 months could not be analysed as data were available from only one study 7 . Two studies 27, 29 showed decreased dyspnoea symptoms at 4-6 weeks after surgery in favour of minimally invasive oesophagectomy. There were no differences between the groups in other function scales (role, emotional, cognitive or social) or symptom scales and items (nausea and vomiting, insomnia, appetite loss, constipation, diarrhoea or financial problems). However, the lack of reporting and inability to obtain the numerical values for these outcomes prevented formal meta-analysis of these outcomes.
Oesophageal cancer-related symptoms (QLQ-OES18)
There were no clinically relevant differences between open and minimally invasive oesophagectomy for most of the QLQ-OES18 outcomes at any time points in any of the studies. Six of the eight studies did not report the numerical data for the outcomes of one or more items. Thus, unbiased meta-analysis of these outcomes could not be performed.
Discussion
This study indicates that minimally invasive surgery is generally followed by better postoperative outcomes regarding global quality of life, physical function, fatigue and pain for up to 3 months after surgery, but these differences fail to persist at 6 or 12 months.
Methodological advantages of this meta-analysis include the strict inclusion criteria, use of well validated questionnaires in all included studies, and application of a cut-off of 10 for MDs to reduce bias from multiple testing 11, 12, 20, 21 . The affected components between the surgical approaches had the same direction of effect at 4-6 weeks and 3 months after surgery in all studies, suggesting an actual effect of the treatment. In addition, the results of the sensitivity analyses, including analyses with studies of only totally minimally invasive operations, were not significantly different from the results of the main analysis. Biases in the individual studies might affect the observed pooled effect size. Visual inspection of the funnel plots revealed no evidence of major small-study effects or publication bias. The effect estimates for clinically significant outcomes in the largest study 29 in the meta-analysis were greater than the average effect estimate. Thus, no adjustment using the trim-and-fill method could be done reliably, as suggested previously 30, 31 . The surgical techniques used were variable in both open and minimally invasive groups. However, all included studies had a thoracotomy and a thoracoscopy group. Patients undergoing open surgery underwent different approaches, such as Ivor Lewis and left-sided transthoracic oesophagectomy 17 . These operations might have different postoperative recovery profiles. Studies included in the 4-6-week outcome analysis were only from Eastern countries, and might not be generalizable for this time point. The results were similar at later time points with Western studies included.
Selective reporting and the inability to obtain the missing data may cause information bias. A weakness was the inability to perform meta-regression and adjust the HRQoL outcomes for confounding, such as neoadjuvant treatment, owing to the small number of studies 32 . Patients selected for minimally invasive surgery might also be healthier than those selected for open operation 7 . Preoperative co-morbidities increase complications, as well as poor quality-of-life outcomes 33, 34 . Similar in-study preoperative baseline HRQoL values between treatment groups should adjust for some of these differences 35, 36 . The 95 per cent prediction intervals were calculated to depict the heterogeneity of the studies. It seems that most patients have better global HRQoL and less fatigue at 3 months, or less pain for up to 3 months after minimally invasive surgery, compared with open surgery. Minimally invasive oesophagectomy might reduce complications, which could be the causal link in the improvements seen in HRQoL up to 3 months following surgery.
Most patients are likely to have some benefit from minimally invasive surgery in less pain for up to 3 months, and less fatigue and better global HRQoL at 3 months after surgery. There are some clinical and research implications that can be distilled from this meta-analysis. Although the 3-month perspective is relevant for patients and healthcare providers, the lack of differences in HRQoL after this interval indicates that open surgery does not need to be abandoned, particularly if the surgeon is more comfortable with an open approach. The learning curve can decrease the prognosis both in the short and long term 37 . This might be a particular concern for complex minimally invasive techniques including oesophagectomy 38 -40 and other procedures 41 -43 . Thus, the findings here are not sufficient to recommend minimally invasive oesophagectomy as standard of care.
Patients want information about HRQoL outcomes after cancer surgery, but surgeons rarely inform the patients about such outcomes 44 . Trauma related to thoracotomy is associated with postoperative pain 45, 46 . Pain and decreased exertion caused by open surgery may have a strong influence on respiratory function, pulmonary complication rate and postoperative HRQoL 47 -49 . The present study can help surgeons to inform patients about general effects on HRQoL when making treatment decisions. Ongoing and future studies and meta-analyses will increase information on the effect of minimally invasive surgery on postoperative HRQoL. Reporting all measured HRQoL outcomes and evaluating the relationship between complications and HRQoL outcomes is important in future studies. 
